Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
Assessment of efficacy of vardenafil in the treatment of subjects with symptomatic Benign
Prostatic Hyperplasia.The purpose of this study is to find out whether vardenafil can improve
the lower urinary tract symptoms of benign prostatic hyperplasia after 8 weeks of daily
administration of 10 mg BID.